1. Home
  2. XENE vs VIRT Comparison

XENE vs VIRT Comparison

Compare XENE & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • VIRT
  • Stock Information
  • Founded
  • XENE 1996
  • VIRT 2008
  • Country
  • XENE Canada
  • VIRT United States
  • Employees
  • XENE N/A
  • VIRT N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • VIRT Investment Bankers/Brokers/Service
  • Sector
  • XENE Health Care
  • VIRT Finance
  • Exchange
  • XENE Nasdaq
  • VIRT Nasdaq
  • Market Cap
  • XENE 2.9B
  • VIRT 2.8B
  • IPO Year
  • XENE 2014
  • VIRT 2015
  • Fundamental
  • Price
  • XENE $39.04
  • VIRT $34.84
  • Analyst Decision
  • XENE Strong Buy
  • VIRT Hold
  • Analyst Count
  • XENE 10
  • VIRT 7
  • Target Price
  • XENE $52.90
  • VIRT $41.43
  • AVG Volume (30 Days)
  • XENE 795.3K
  • VIRT 968.0K
  • Earning Date
  • XENE 11-03-2025
  • VIRT 10-29-2025
  • Dividend Yield
  • XENE N/A
  • VIRT 2.76%
  • EPS Growth
  • XENE N/A
  • VIRT 132.69
  • EPS
  • XENE N/A
  • VIRT 4.62
  • Revenue
  • XENE $7,500,000.00
  • VIRT $2,694,104,000.00
  • Revenue This Year
  • XENE N/A
  • VIRT N/A
  • Revenue Next Year
  • XENE $207.88
  • VIRT N/A
  • P/E Ratio
  • XENE N/A
  • VIRT $7.53
  • Revenue Growth
  • XENE N/A
  • VIRT 41.05
  • 52 Week Low
  • XENE $26.74
  • VIRT $31.10
  • 52 Week High
  • XENE $46.00
  • VIRT $45.77
  • Technical
  • Relative Strength Index (RSI)
  • XENE 41.74
  • VIRT 54.38
  • Support Level
  • XENE $37.63
  • VIRT $33.83
  • Resistance Level
  • XENE $42.96
  • VIRT $35.43
  • Average True Range (ATR)
  • XENE 1.60
  • VIRT 0.87
  • MACD
  • XENE -0.47
  • VIRT 0.32
  • Stochastic Oscillator
  • XENE 21.42
  • VIRT 76.61

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

Share on Social Networks: